Clik here to view.
Women With Severe Maternal Morbidity Less Likely to Have Subsequent Birth
MONDAY, Nov. 25, 2024 (HealthDay News) — Women who experience severe maternal morbidity (SMM) in the first birth are less likely to have a subsequent birth, according to a study published online Nov....
View ArticleClik here to view.
Studies Examine Cost-Effectiveness of Maternal RSV Vaccination, Nirsevimab in...
MONDAY, Nov. 25, 2024 (HealthDay News) — Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published...
View ArticleClik here to view.
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With...
MONDAY, Nov. 25, 2024 (HealthDay News) — Muvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American Medical Association to coincide with the...
View ArticleClik here to view.
AHA: Bumetanide Nasal Spray Statistically Bioequivalent to Oral Bumetanide
MONDAY, Nov. 25, 2024 (HealthDay News) — Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter published online Nov. 18 in Circulation to...
View ArticleClik here to view.
RSNA: Levothyroxine Tied to Bone Loss Over Time in Older Adults
MONDAY, Nov. 25, 2024 (HealthDay News) — Levothyroxine (LT4) use is associated with longitudinal loss of bone mass and density in older adults, according to a study scheduled to be presented at the...
View ArticleClik here to view.
Heart Failure With Preserved Ejection Fraction Underdiagnosed
MONDAY, Nov. 25, 2024 (HealthDay News) — Heart failure with preserved ejection fraction (HFpEF) is underdiagnosed in patients with severe secondary tricuspid regurgitation (STR) of undefined etiology...
View ArticleClik here to view.
In Utero Exposure to Certain Antiepileptics Tied to Neurodevelopmental Diagnoses
MONDAY, Nov. 25, 2024 (HealthDay News) — Exposure to certain antiseizure medications (ASMs) in utero is associated with an increased likelihood of neurodevelopmental diagnoses, according to a study...
View ArticleClik here to view.
COVID-19, Flu, RSV Vaccine Coverage Low for Adults in 2024 to 2025 Season
MONDAY, Nov. 25, 2024 (HealthDay News) — COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025),...
View ArticleClik here to view.
1999 to 2020 Saw Twofold Increase in Alcohol-Related Mortality in the U.S.
MONDAY, Nov. 25, 2024 (HealthDay News) — From 1999 to 2020, there was a significant approximately twofold increase in alcohol-related mortality in the United States, according to a study published...
View ArticleHip replacement superior to resistance training in severe hip osteoarthritis
1. In this randomized controlled trial, total hip replacement (THR) was superior to resistance training in improving hip pain and function in patients with severe hip osteoarthritis. 2. The incidence...
View ArticleAsciminib improves outcomes in chronic myeloid leukemia
1. In this randomized controlled trial, among adults diagnosed with chronic myeloid leukemia (CML), asciminib demonstrated a significantly higher major molecular response (MMR) rate compared to...
View ArticleEarly Ramucirumab/Paclitaxel vs Continuation of First-line Chemotherapy in...
1. Median PFS was 6.6 months in the switch maintenance group and 3.5 months in the control group with HR 0.61 (significant). 2. Treatment-related adverse events grade 3 or worse occurred in 40% of the...
View ArticleAdjuvant dabrafenib and trametinib improve survival in stage III melanoma
1. After almost 10 years of follow-up, adjuvant dabrafenib and trametinib improved relapse-free and metastasis-free survival compared to placebo in patients with resected stage III melanoma. 2. Overall...
View ArticleCases of neurodevelopmental disorders caused by mutated lncRNA CHASERR
1. Three unrelated children were found to have a de novo deletion in the long non-coding RNA (lncRNA) CHASERR, which is adjacent to the chromodomain helicase DNA-binding protein 2 (CHD2), resulting in...
View ArticleAnti-Fraud Efforts Meet Real-World Test During ACA Enrollment Period
Unauthorized switching of Affordable Care Act plans appears to have tapered off in recent weeks based on an almost one-third drop in casework associated with consumer complaints, say federal...
View ArticleImpact of Smartphone Apps on Self-Management in RA
The following is a summary of “A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomised controlled AEGORA trial,” published in the November...
View ArticleEarly-Start Medication Abortion Noninferior to Standard Treatment for Completion
The following is a summary of “Randomized Trial of Very Early Medication Abortion,” published in the November 2024 issue of Obstetrics and Gynecology by Brandell et al. Medication abortion involving...
View ArticleMetabolic Alterations and Asprosin Levels in Adults with Growth Hormone...
The following is a summary of “Association Between the Serum Level of Asprosin and Metabolic Parameters in Adult Growth Hormone Deficiency: A Cross-Sectional Study,” published in the November 2024...
View ArticleNomograms for Predicting Overall and CSS in Patients with CRC
The following is a summary of “Developing and validation a prognostic model for predicting prognosis among synchronous colorectal cancers patients using combined log odds ratio of positive lymph nodes:...
View ArticleALKY Demonstrates Efficacy in dMGMT-NETs in Pancreatic and Thoracic Cancers
The following is a summary of “Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study...
View Article